Tang Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $641K | Hold |
100,000
| – | – | 0.03% | 180 |
|
|
2025
Q1 | $354K | Hold |
100,000
| – | – | 0.02% | 189 |
|
|
2024
Q4 | $378K | Hold |
100,000
| – | – | 0.03% | 174 |
|
|
2024
Q3 | $324K | Hold |
100,000
| – | – | 0.02% | 138 |
|
|
2024
Q2 | $190K | Hold |
100,000
| – | – | 0.02% | 125 |
|
|
2024
Q1 | $284K | Sell |
100,000
-100,000
| -50% | -$284K | 0.03% | 97 |
|
|
2023
Q4 | $2.94M | Buy |
+200,000
| New | +$2.94M | 0.27% | 79 |
|
|
2023
Q3 | – | Sell |
-100,000
| Closed | -$2.16M | – | 107 |
|
|
2023
Q2 | $2.16M | Hold |
100,000
| – | – | 0.32% | 69 |
|
|
2023
Q1 | $2.93M | Hold |
100,000
| – | – | 0.44% | 57 |
|
|
2022
Q4 | $3.7M | Buy |
+100,000
| New | +$3.7M | 0.54% | 45 |
|